Late Friday, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on the proposed rule for the 2024 Medicare Physician Fee Schedule.
Today, the Biden Administration released the first list of 10 drugs for Medicare price negotiation, including Imbruvica, a cancer drug used to treat certain types of leukemia and lymphoma.
More than 300,000 individuals were disenrolled from the state Medicaid program since the state began its Medicaid redetermination process four months ago, which includes 15,000 newborns removed since Arkansas resumed eligibility reviews in Medicaid following the end of the COVID-19 pandemic.
Today, the Centers for Medicare and Medicaid Services (CMS) released the first monthly data report on the unwinding of Medicaid continuous coverage following the expiration of pandemic-era protections that prompted an eligibility redetermination process led by state agencies.
Yesterday, First Lady Dr. Jill Biden held a call with cancer advocacy organizations to discuss the administration’s commitment to increase access to patient navigation services through reimbursement in Medicare.
The Center for Medicare and Medicaid Services (CMS) released the proposed Calendar Year 2024 Medicare Physician Fee Schedule, including coding changes to allow for reimbursement for some patient navigation services and expanded access to telehealth services.
Today, U.S. Senators Tammy Baldwin (D-WI) and Shelley Moore Capito (R-WV) reintroduced S. 2243 Palliative Care and Hospice Education and Training Act (PCHETA). The bipartisan bill would create a national public education and awareness campaign to educate patients and providers about the availability and benefits of palliative care, expand federal research regarding palliative care, including pain and symptom management, and establish palliative care education and training programs for doctors, nurses and other health professionals.
Today the Department of Health and Human Services, Department of Labor and the Treasury Department jointly released a proposed rule that would return the sale of short-term limited duration insurance plans (STLD) to a limit of 90 days. This is similar to rules that were in place prior to 2018, but under the proposed rule would apply to all STLD plans created after the final rule is issued. The proposed rule would also require STLD issuers to comply with new notice requirements to help consumers distinguish between an STLD plan and comprehensive health coverage.
Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief in the case of Braidwood v. Becerra in the U.S. Court of Appeals for the Fifth Circuit in support of the Department of Justice (DOJ)’s defense of the Affordable Care Act (ACA) provisions requiring private insurers provide coverage of certain evidence-based preventive services without cost-sharing. The amicus brief provides extensive scientific data to the appeals court demonstrating that preventive services save lives and are cost-effective, as well as examples of the cost-free services that would be lost for many patients if the lower court’s decision is upheld.